Crystalline Fructose - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The crystalline fructose market size is projected to be USD 870.34 million in 2025, USD 901.25 million in 2026, and reach USD 998.87 million by 2031, growing at a CAGR of 5.24% from 2026 to 2031. This report is Segmented by Source (Starch Hydrolysis and Sucrose Hydrolysis), Application (Food and Beverages, Pharmaceuticals, Dietary Supplements, Personal Care and Cosmetics, and Others), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Crystalline Fructose Market Trends and Insights

Rising Demand for Low-Calorie Sweetening Systems in Reformulated Foods

Product reformulation has moved into routine sourcing decisions, and that shift is supporting the crystalline fructose market in packaged food and beverage. ADM reported in January 2026 that more than 80% of U.S. consumers preferred reformulated better-for-you products, and 83% of global consumers were reducing sugar intake, which is pushing manufacturers to revisit their sweetener systems. Crystalline fructose remains useful in these programs because Tate & Lyle states that its glycemic index is close to 15 compared with 65 for sucrose, while its sweetness efficiency can support a 20.00% to 30.00% reduction in sweetener mass in suitable formulations. The crystalline fructose market is also helped by the fact that sweetness perception increases in colder and more acidic conditions, which gives formulators a practical tool in chilled beverages and functional drinks where some alternatives do not perform as well. That combination of reduced sugar load, technical performance, and easier claim support is making crystalline fructose a more relevant input for mid-tier manufacturers that do not want highly complex multi-sweetener systems.

Increase in Demand for High-Purity Ingredients in Nutraceutical and Pharmaceutical Formulations

The crystalline fructose market is gaining from the tighter quality needs of pharmaceutical and nutraceutical formulations. Pharmaceutical-grade supply depends on validated production, controlled impurity levels, and compliance with formal purity standards, which narrows the field of suppliers that can serve this demand. Ingredion announced in May 2026 that it partnered with Sanstar Limited and backed a greenfield specialty ingredient plant in India, a move aimed at pharmaceutical excipient and clean-label food demand. This matters because pediatric oral products, chewables, syrups, and dispersible formats need taste masking and consistent quality, and those needs support the use of crystalline fructose beyond ordinary food sweetening. The crystalline fructose market is therefore seeing demand that is less tied to short-term consumer cycles and more tied to specification-driven formulation work in regulated end uses.

Feedstock Price Volatility in Corn, Sugar Cane, and Sugar Beet Supply Chains

Feedstock volatility remains a direct restraint on the crystalline fructose market because production economics are tied to agricultural cycles and competing end uses. The U.S. EPA’s 2026 and 2027 Renewable Fuel Standard supports corn use in ethanol, which can tighten starch availability for wet millers during high-demand periods and affect sweetener margins. The draft also shows that large producers are responding through vertical integration and plant modernization. ADM announced a USD 103 million modernization of its Decatur, Illinois operations in 2026, while Xiwang highlights its large annual corn processing base in Shandong, which helps both companies manage sourcing risk more effectively than smaller standalone producers. The crystalline fructose market therefore remains more exposed where suppliers lack long-term feedstock control or integrated processing systems.

Other drivers and restraints analyzed in the detailed report include:

• Clean-Label Replacement of Artificial Sweeteners in Premium Beverage Formats
• Precision Crystallization and Enzymatic Yield Improvements
• Competition From Stevia, Erythritol, Monk Fruit, and High Fructose Corn Syrup

Segment Analysis

Starch hydrolysis accounted for 64.38% of revenue in 2025, giving it the leading position in the crystalline fructose market because of its long-established base in corn wet milling. The segment benefits from accumulated infrastructure in the U.S. Corn Belt and major Chinese starch clusters, where integrated milling and sweetener processing support scale economics. Xiwang states that its sugar business operates China’s first domestically developed large-scale corn fructose production line, processes 3 million tonnes of corn annually, and holds 5 pharmaceutical approval numbers, which shows how scale and product range can sit inside one production platform. The crystalline fructose industry continues to rely on this route for broad commercial supply because starch-based processing supports both food-grade output and the gradual move into higher-purity grades.

The sucrose hydrolysis route is forecast to expand at a 6.73% CAGR through 2031, making it the faster-growing pathway in the crystalline fructose market. This growth is tied to demand for non-GMO and beet sugar-derived material, especially in Europe and North America, where feedstock provenance carries commercial value beyond sweetness alone. Galam states that Fruitose® is produced from non-GMO European sugar beet and delivers purity of at least 99.50% on a dry-weight basis, which supports its use in premium food, supplement, and clean-label channels. Galam also renewed its Non-GMO Project certifications in March 2026, reinforcing the premium position of this route in channels where documentation and ingredient origin matter.

Complete Report Scope:

• Source
  • Starch Hydrolysis
  • Sucrose Hydrolysis
• Application
  • Food and Beverages
  • Pharmaceuticals
  • Dietary Supplements
  • Personal Care and Cosmetics
  • Other Applications
• Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific held 32.48% of revenue in 2025, which gave the region the largest share of the crystalline fructose market. China anchors that position through deep starch processing capacity and integrated corn-based production, while India is becoming more relevant through pharmaceutical and specialty ingredient demand. Xiwang states that it processes 3 million tonnes of corn annually and holds the leading domestic position in Chinese crystalline fructose capacity, output, and share, which highlights the scale available in the region. The crystalline fructose market in Asia-Pacific also benefits from a wider mix of end uses, including food reformulation, functional products, and ingredient exports. India is becoming a more important demand node because Ingredion’s May 2026 partnership with Sanstar directly targets pharmaceutical excipient and clean-label ingredient needs in the country.

North America remained the second-largest regional market in the crystalline fructose market, supported by the depth of corn wet milling infrastructure in the United States. ADM’s Decatur complex is undergoing USD 103 million in modernization in 2026, which strengthens an already important sweetener supply base for domestic and export demand. Tate & Lyle’s Lafayette, Indiana facility has also long been a reference point for North American food-grade and industrial crystalline fructose supply. The crystalline fructose market in the region continues to benefit from reformulation work in beverages, dairy, and broader processed food categories.

Europe is projected to expand at a 6.57% CAGR through 2031, making it the fastest-growing regional part of the crystalline fructose market size in the forecast period. The region’s growth comes from demand for natural, non-GMO, and transparent sweetener positioning in food and beverage labels. EU rules on nutrition and health claims support reduced-sugar product development, and the mass reduction advantage of crystalline fructose can fit that direction in suitable applications. Galam’s beet sugar-derived product line is well aligned with this environment because provenance and documentation are important in premium European channels.

List of Companies Covered in this Report:

• Archer Daniels Midland Company
• Tate & Lyle PLC
• Cargill, Incorporated
• Ingredion Incorporated
• Galam Ltd.
• Danisco A/S
• Foodchem International Corporation
• Farbest Brands
• Hebei Huaxu Pharmaceutical Co., Ltd.
• Shandong Xiwang Sugar Industry Co., Ltd.
• COFCO Rongshi Biotechnology Co., Ltd.
• Roquette Frères
• Tereos S.A.
• Agrana Beteiligungs-AG
• Japan Corn Starch Co., Ltd.
• Sam-Yang Corporation
• Bell Chem Corp.
• Hugestone Enterprise Co. Ltd.
• Anhui Elite Industrial Co., Ltd.
• Cika Food Ingredients Co. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support